Columns to expect this week and next:
- Update on Follow-on Biologics and the Dance of Legislation
- Status of FDA Appropriations
- How FDA Could Be Affected by Health Reform Legislation
- Exploring the Office of Regulatory Affairs
Columns to expect this week and next: